How cannabis and psilocybin might help those experiencing chronic pain
PsyPost -

The U.S. Drug Enforcement Agency announced in late April 2024 that it plans to ease federal restrictions on cannabis, reclassifying it from a Schedule I drug to the less restricted Schedule III, which includes drugs such as Tylenol with codeine, testosterone and other anabolic steroids. This historic shift signals an acknowledgment of the promising medicinal value of cannabis. The move comes in tandem with growing interest in the use of psilocybin, the active component in magic mushrooms, for...

In related news